Transcriptional response of kidney tissue after 177Lu-octreotate administration in mice

Nuclear Medicine and Biology

Volumn 41, Issue 3, 2014, Pages 238-247

  Schüler, Emil ^a   Rudqvist, Nils ^a   Parris, Toshima Z ^a   Langen, Britta ^a   Helou, Khalil ^a   Forssell Aronsson, Eva ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Kidney response; Lu 177; Radiation biology; Radionuclide therapy; Transcriptional gene regulation

Indexed keywords

KIDNEY RESPONSE; LU-177; RADIATION BIOLOGY; RADIONUCLIDE THERAPY; TRANSCRIPTIONAL GENE REGULATION;

ANIMALS; FEMALE; INJECTIONS; KIDNEY CORTEX; KIDNEY MEDULLA; MICE; MICE, INBRED BALB C; OCTREOTIDE; RADIATION DOSAGE; RADIOMETRY; TRANSCRIPTION, GENETIC;

EID: 84893951820     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.12.001     Document Type: Article

References (42)

1. 3]octreotate. J Nucl Med 2011, 52:1361-1368.
2. 3]-octreotate treatment in patients with disseminated gastroenteropancreatic neuroendocrine tumors: the value of measuring absorbed dose to the kidney. World J Surg 2010, 34:1368-1372.
3. 1-octreotide. Acta Oncol 2004, 43:436-442.
4. 1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med 2000, 41:636-642.
5. de Jong M., Rolleman E.J., Bernard B.F., Visser T.J., Bakker W.H., Breeman W.A., et al. Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. J Nucl Med 1996, 37:1388-1392.
6. Christensen E.I., Nielsen S. Structural and functional features of protein handling in the kidney proximal tubule. Semin Nephrol 1991, 11:414-439.
7. Vegt E., de Jong M., Wetzels J.F., Masereeuw R., Melis M., Oyen W.J., et al. Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention. J Nucl Med 2010, 51:1049-1058.
8. Forssell-Aronsson E., Spetz J., Ahlman H. Radionuclide therapy via SSTR: future aspects from experimental animal studies. Neuroendocrinology 2013, 97:86-98.
9. Kolby L., Bernhardt P., Johanson V., Schmitt A., Ahlman H., Forssell-Aronsson E., et al. Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. Br J Cancer 2005, 93:1144-1151.
10. 111In-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT2. Oncol Rep 2012, 27:174-181.
11. 177Lu-octreotate: comparison between methods based on planar scintigraphy. EJNMMI Res 2012, 2:49.
12. 3-octreotate. J Nucl Med 2005, 46(Suppl 1):83S-91S.
13. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
14. Lambert B., Cybulla M., Weiner S.M., Van De Wiele C., Ham H., Dierckx R.A., et al. Renal toxicity after radionuclide therapy. Radiat Res 2004, 161:607-611.
15. 177Lu]-DOTATATE in nude mice. Nucl Med Biol 2012, 39:756-762.
16. 90Y-DOTATOC. Eur J Nucl Med 2001, 28:1552-1554.
17. Otte A., Herrmann R., Heppeler A., Behe M., Jermann E., Powell P., et al. Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med 1999, 26:1439-1447.
18. Pool S.E., Krenning E.P., Koning G.A., van Eijck C.H., Teunissen J.J., Kam B., et al. Preclinical and clinical studies of peptide receptor radionuclide therapy. Semin Nucl Med 2010, 40:209-218.
19. Kruse J.J., te Poele J.A., Velds A., Kerkhoven R.M., Boersma L.J., Russell N.S., et al. Identification of differentially expressed genes in mouse kidney after irradiation using microarray analysis. Radiat Res 2004, 161:28-38.
20. Taki K., Wang B., Nakajima T., Wu J., Ono T., Uehara Y., et al. Microarray analysis of differentially expressed genes in the kidneys and testes of mice after long-term irradiation with low-dose-rate gamma-rays. J Radiat Res (Tokyo) 2009, 50:241-252.
21. Zhao W., Chuang E.Y., Mishra M., Awwad R., Bisht K., Sun L., et al. Distinct effects of ionizing radiation on in vivo murine kidney and brain normal tissue gene expression. Clin Cancer Res 2006, 12:3823-3830.
22. 131I on gene expression in normal tissues in Balb/c mice. EJNMMI Res 2011, 1:29.
23. 211At. J Nucl Med 2013, 54:990-998.
24. Loevinger R., Budinger T.F., Watson E.E. MIRD primer for absorbed dose calculations 1988, Society of Nuclear Medicine.
25. 177Lu radionuclides. Cancer Biother Radiopharm 2005, 20:436-449.
26. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.
27. Melis M., Krenning E.P., Bernard B.F., Barone R., Visser T.J., de Jong M. Localisation and mechanism of renal retention of radiolabelled somatostatin analogues. Eur J Nucl Med Mol Imaging 2005, 32:1136-1143.
28. 111In-DTPA]octreotide. J Nucl Med 2004, 45:1168-1171.
29. Konijnenberg M., Melis M., Valkema R., Krenning E., de Jong M. Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy. J Nucl Med 2007, 48:134-142.
30. Rudqvist N., Parris T.Z., Schuler E., Helou K., Forssell-Aronsson E. Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles. EJNMMI Res 2012, 2:32.
31. Heinloth A.N., Shackelford R.E., Innes C.L., Bennett L., Li L., Amin R.P., et al. ATM-dependent and -independent gene expression changes in response to oxidative stress, gamma irradiation, and UV irradiation. Radiat Res 2003, 160:273-290.
32. Heinloth A.N., Shackelford R.E., Innes C.L., Bennett L., Li L., Amin R.P., et al. Identification of distinct and common gene expression changes after oxidative stress and gamma and ultraviolet radiation. Mol Carcinog 2003, 37:65-82.
33. Rashi-Elkeles S., Elkon R., Shavit S., Lerenthal Y., Linhart C., Kupershtein A., et al. Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol Oncol 2011, 5:336-348.
34. Sriharshan A., Boldt K., Sarioglu H., Barjaktarovic Z., Azimzadeh O., Hieber L., et al. Proteomic analysis by SILAC and 2D-DIGE reveals radiation-induced endothelial response: four key pathways. J Proteomics 2012, 75:2319-2330.
35. Snyder A.R., Morgan W.F. Gene expression profiling after irradiation: clues to understanding acute and persistent responses?. Cancer Metastasis Rev 2004, 23:259-268.
36. Chaudhry M.A. Biomarkers for human radiation exposure. J Biomed Sci 2008, 15:557-563.
37. Filiano A.N., Fathallah-Shaykh H.M., Fiveash J., Gage J., Cantor A., Kharbanda S., et al. Gene expression analysis in radiotherapy patients and C57BL/6 mice as a measure of exposure to ionizing radiation. Radiat Res 2011, 176:49-61.
38. Langen B. Fundamental studies on high-LET radiation induced DNA damage in vitro and transcriptional responses in vivo 2013, Licentiate thesis, Department of Applied Physics: Chalmers University of Technology, Gothenburg, Sweden.
39. Vaidya V.S., Ozer J.S., Dieterle F., Collings F.B., Ramirez V., Troth S., et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 2010, 28:478-485.
40. Han W.K., Bailly V., Abichandani R., Thadhani R., Bonventre J.V. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002, 62:237-244.
41. Vaidya V.S., Ferguson M.A., Bonventre J.V. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 2008, 48:463-493.
42. Adiyanti S.S., Loho T. Acute kidney injury (AKI) biomarker. Acta Med Indones 2012, 44:246-255.